Menu
Home
About
About Us
Our Team
Publications
Platform
CAR-γδ T Cell
iPSC-γδ NKT Cell
Pipeline
Manufacturer
Investors
Contact Us
Shareholder Benefits
Make An Appointment
Human dendritic cells derived from embryonic stem cells stably modified with CD1d efficiently stimulate antitumor invariant natural killer T cell response
«
Antigenically modified human pluripotent stem cells generate antigen-presenting dendritic cells
Enhancing immunostimulatory function of human embryonic stem cell-derived dendritic cells by CD1d overexpression
»